跳至主要内容
临床试验/ACTRN12614001056684
ACTRN12614001056684招募中2 期

Pilot study evaluating progression-free survival in patients using a ketogenic diet while receiving chemoradiation for glioblastoma multiforme

Waikato District Health Board0 个研究点目标入组 20 人开始时间: 2014年10月3日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
o limit 至 o limit(—)
性别
All

入选标准

  • * Patients with biopsy-proven glioblastoma multiforme who are considered suitable for standard chemoradiation (including adequate performance status and bone marrow, hepatic and liver function).
  • * Patients must be mentally competent to understand the requirements of the diet and believe that they, with the support of their carers, are capable of achieving them.
  • * Patients have given written informed consent

排除标准

  • * Diabetic patients who are at risk of hypoglycaemic events (such as those on insulin or sulphonylureas)
  • * Current pregnancy or breast-feeding

研究者

相似试验